Literature DB >> 6301614

High dose of antacid reduces bioavailability of ranitidine.

K Frislid, A Berstad.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301614      PMCID: PMC1547647          DOI: 10.1136/bmj.286.6374.1358-b

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  Relationship between ranitidine plasma levels and reduction of postprandial intragastric acidity in healthy man.

Authors:  A Berstad; K Frislid; A Rydning
Journal:  Scand J Gastroenterol       Date:  1982-01       Impact factor: 2.423

2.  Controlled clinical trial of duodenal ulcer healing with antacid tablets.

Authors:  A Berstad; A Rydning; E Aadland; B Kolstad; K Frislid; J Aaseth
Journal:  Scand J Gastroenterol       Date:  1982-10       Impact factor: 2.423

3.  Cimetidine plasma concentration-response relationships.

Authors:  R Gugler; G Fuchs; M Dieckmann; A A Somogyi
Journal:  Clin Pharmacol Ther       Date:  1981-06       Impact factor: 6.875

  3 in total
  6 in total

Review 1.  Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.

Authors:  J H Lin
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

3.  Effect of aluminum phosphate on the bioavailability of ranitidine.

Authors:  H Albin; G Vinçon; B Begaud; C Bistue; P Perez
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 4.  Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.

Authors:  J G Hatlebakk; A Berstad
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

Review 5.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of ranitidine.

Authors:  C J Roberts
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.